HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage

Journal of Reproductive Immunology

Volumn 116, Issue , 2016, Pages 28-34

  Meuleman, T ^a   van Beelen, E ^a   Kaaja, R J ^b   van Lith, J M M ^a   Claas, F H J ^a   Bloemenkamp, K W M ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Finland   (Finland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

HLA antibodies; Humoral rejection; Immunology; Pregnancy; Recurrent miscarriage

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA C ANTIGEN; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT; PROTEIN BINDING;

ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY SCREENING; ARTICLE; CASE CONTROL STUDY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOPHILIA; TROPHOBLAST; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; FIRST TRIMESTER PREGNANCY; IMMUNOLOGY; METABOLISM; PREGNANCY;

ABORTION, HABITUAL; ADULT; ANTIBODIES; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; COMPLEMENT C4B; FEMALE; HLA-C ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTEIN BINDING; TROPHOBLASTS;

EID: 84965000104     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2016.03.003     Document Type: Article

References (34)

1. Agrawal S., Pandey M.K., Mandal S., Mishra L., Agarwal S. Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth 2002, 2:6.
2. Bartel G., et al. Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage. Hum. Immunol. 2011, 72:187-192.
3. Billen E.V., Voorter C.E., Christiaans M.H., van den Berg-Loonen E.M. Luminex donor-specific crossmatches. Tissue Antigens 2008, 71:507-513.
4. Branch D.W., Gibson M., Silver R.M. Clinical practice. Recurrent miscarriage. N. Engl. J. Med. 2010, 363:1740-1747.
5. Chan Y.Y., Jayaprakasan K., Zamora J., Thornton J.G., Raine-Fenning N., Coomarasamy A. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum. Reprod. Update 2011, 17:761-771.
6. Coulam C.B. Epidemiology of recurrent spontaneous abortion. Am. J. Reprod. Immunol. 1991, 26:23-27.
7. Coulam C.B. Immunologic tests in the evaluation of reproductive disorders: a critical review. Am. J. Obstet. Gynecol. 1992, 167:1844-1851.
8. Dankers M.K., et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004, 77:1236-1239.
9. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum. Immunol. 2002, 63:339-352.
10. Giannakopoulos B., Passam F., Ioannou Y., Krilis S.A. How we diagnose the antiphospholipid syndrome. Blood 2009, 113:985-994.
11. Girardi G., Redecha P., Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 2004, 10:1222-1226.
12. Kishore R., Agarwal S., Halder A., Das V., Shukla B.R., Agarwal S.S. HLA sharing, anti-paternal cytotoxic antibodies and MLR blocking factors in women with recurrent spontaneous abortion. J. Obstet. Gynaecol. Res. 1996, 22:177-183.
13. Kloosterman G.J. On intrauterine growth. The significance of prenatal care. Int. J. Gynaecol. Obstet. 1970, 8:895-912.
14. Larsen E.C., Christiansen O.B., Kolte A.M., Macklon N. New insights into mechanisms behind miscarriage. BMC Med. 2013, 11:154.
15. Lashley E.E., Meuleman T., Claas F.H. Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am. J. Reprod. Immunol. 2013, 70:87-103.
16. Lee J., et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and c4d. PLoS One 2011, 6:e16806.
17. Loupy A., et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N. Engl. J. Med. 2013, 369:1215-1226.
18. McNamee K., Dawood F., Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr. Opin. Obstet. Gynecol. 2012, 24:229-234.
19. Meuleman T., Cohen D., Swings G.M., Veraar K., Claas F.H., Bloemenkamp K.W. Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage. J. Reprod. Immunol. 2015, 113:54-60.
20. Nielsen H.S., Andersen A.M., Kolte A.M., Christiansen O.B. A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study. Fertil. Steril. 2008, 89:907-911.
21. Nielsen H.S., et al. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum. Reprod. 2010, 25:1543-1552.
22. Nielsen H.S., et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J. Reprod. Immunol. 2010, 87:67-73.
23. Ooi P.V., Russell N., O'Donoghue K. Secondary recurrent miscarriage is associated with previous male birth. J. Reprod. Immunol. 2011, 88:38-41.
24. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005, 365:1570-1576.
25. Pandey M.K., Rani R., Agrawal S. An update in recurrent spontaneous abortion. Arch. Gynecol. Obstet. 2005, 272:95-108.
26. Pasquier E., et al. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial. Blood 2015, 125:2200-2205.
27. Rai R., Regan L. Recurrent miscarriage. Lancet 2006, 368:601-611.
28. Regan L., Braude P.R., Hill D.P. A prospective study of the incidence: time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum. Reprod. 1991, 6:294-298.
29. Schleussner E., Petroff D. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss. Ann. Intern. Med. 2015, 163:485.
30. Terasaki P.I., Bernoco D., Park M.S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award lecture. Am. J. Clin. Pathol. 1978, 69:103-120.
31. van Kampen C.A., Versteeg-van der Voort Maarschalk M.F., Langerak-Langerak J., van B.E., Roelen D.L., Claas F.H. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum. Immunol. 2001, 62:201-207.
32. Visser J., et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb. Haemost. 2011, 105:295-301.
33. Yang C.J., Stone P., Stewart A.W. The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. Aust. N. Z. J. Obstet. Gynaecol. 2006, 46:316-322.
34. Zoet Y.M., Brand-Schaaf S.H., Roelen D.L., Mulder A., Claas F.H., Doxiadis I.I. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?. Tissue Antigens 2011, 77:225-228.